(Total Views: 337)
Posted On: 06/17/2020 11:30:41 AM
Post# of 81
$ATRA News Article - Atara Biotherapeutics Announces First Patient Enrolled in Randomized Placebo-Controlled Study of Allogeneic T-cell Therapy ATA188 in Progressive Forms of Multiple Sclerosis https://marketwirenews.com/news-releases/atar...88828.html
(0)
(0)
My Twitter: WhyteStocks
